Skip to main content

Table 4 Standardised beta weights for the mean response to identify the factors predicting changes to treatment

From: Designing a mHealth clinical decision support system for Parkinson’s disease: a theoretically grounded user needs approach

Factor

Care Plan

Levodopa

Dopamine Agonist

Bradykinesia

.36

.31

.14

Tremor

.51

.47

.44

Gait

−.02

.16

−.04

Dyskinesia

.19

−.29

.31

Motor Fluctuations

.44

.44

−.16

Sleep

.10

.04

.19

Cognition

.23

.27

.00

Impulsivity

−.09

−.07

−.36

Depression

.22

.08

.27

Constipation

−.02

−.10

.06

Rigidity

.35

.41

.34

Age

−.31

−.07

.00

Employment

−.37

−.29

.26

Model R2

0.82

0.90

0.70

  1. N.B. for symptoms, a positive beta weight implies an increased likelihood of change to the care plan, or an increased level of medication, in response to worsening symptoms